Trial in phage therapy for burn infections
Trial in phage therapy for burn infections
A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.
4 Oct 2018
•
29mins
Pandemic influenza: 100 years
Pandemic influenza: 100 years
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can... Read more
21 Jun 2018
•
19mins
Similar Podcasts
Let's Talk ID
Emerging Infectious Diseases
Listen to The Lancet Global Health
Persiflagers Infectious Disease Puscast
Listen to The Lancet Respiratory Medicine
The Lancet News
Listen to The Lancet
Listen to The Lancet Diabetes & Endocrinology
Listen to The Lancet Haematology
Listen to The Lancet Gastroenterology & Hepatology
Listen to The Lancet Gastroenterology & Hepatology
Listen to The Lancet Neurology
USF Health’s IDPodcasts
PeerView Infectious Diseases CME/CNE/CPE Audio Podcast
A Gobbet o' Pus
Pandemic influenza: 100 years
Pandemic influenza: 100 years
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can... Read more
21 Jun 2018
•
19mins
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delaman... Read more
14 Feb 2018
•
15mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delaman... Read more
14 Feb 2018
•
15mins
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibo... Read more
10 Jan 2018
•
12mins
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibo... Read more
10 Jan 2018
•
12mins
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.
18 Oct 2017
•
7mins
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.
18 Oct 2017
•
7mins
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017
Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan.
14 Aug 2017
•
16mins
